Overview and Scope
Prescription to over-the-counter (Rx-to-OTC) switches refer to the process of approving prescription medications for sale over-the-counter (OTC), allowing consumers to acquire it without a prescription. This move attempts to make drugs more affordable and accessible by eliminating the need for doctor visits and prescription drug coverage.
Sizing and Forecast
The prescription to over-the-counter (Rx-to-OTC) switches market size has grown strongly in recent years. It will grow from $39.41 billion in 2023 to $42.76 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to growth in consumer preference for self-care, increased considerable investments in the healthcare sector and innovations, growth in Government agencies support, increased awareness and knowledge about OTC products, Change in health priorities influencing.
The prescription to over-the-counter (Rx-to-OTC) switches market size is expected to see strong growth in the next few years. It will grow to $59.58 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to growing demand for OTC drugs, rising insurance and reimbursement policies, increasing consumer interest in self-care and self-medication, growing aging population, increased awareness and education about OTC medications. Major trends in the forecast period include increasing consumer demand for self-care, digital health integration, growth of store brands and private labels, innovative drug delivery systems, growing emphasis on preventive care products.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/prescription-to-over-the-counter-rx-to-otc-switches-global-market-report
Segmentation & Regional Insights
The prescription to over-the-counter (Rx-to-OTC) switches market covered in this report is segmented –
1) By Product: Allergy And Respiratory, Fungal Infections And Other Infections, Oral Contraceptive, Gastrointestinal Drugs, Other Products
2) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Drug Stores, Online Pharmacies
3) By End-User: Hospital-Based Laboratories And Clinics, Diagnostic Laboratories, Academic Research Institutes
Top 5 Major Players:
North America was the largest region in the prescription to over-the-counter (Rx-to-OTC) switches market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prescription to over-the-counter (Rx-to-OTC) switches market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15640&type=smp
Major Driver Impacting Market Growth
The growing consumer demand for OTC products is expected to propel the growth of the prescription to over-the-counter (Rx-to-OTC) switches market going forward. Over-the-counter (OTC) products are pharmaceuticals that can be acquired without a prescription from a healthcare provider. The demand for over-the-counter (OTC) products has increased due to several reasons, such as accessibility, time-saving, awareness and education, digital health, and e-commerce. OTC products offer easy access, empowering patients to self-manage common ailments and make informed treatment choices without needing a prescription, fostering autonomy and informed decision-making in healthcare. For instance, in January 2024, the Consumer Healthcare Products Association (CHPA), a US-based trade association, reported an increase in OTC medicine retail sales of $43.4 billion in 2023 compared to $42.1 billion in 2022. Therefore, the growing consumer demand for OTC products is driving the growth of the Rx-to-OTC switches market.
Key Industry Players
Major companies operating in the prescription to over-the-counter (Rx-to-OTC) switches market are Pfizer Inc., Johnson & Johnson, Procter & Gamble Company, Merck & Co. Inc, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb, AstraZeneca plc , Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly & Company Ltd., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Alcon Inc., Boehringer Ingelheim GmbH , Sun Pharmaceutical Industries Ltd, Dr Reddy’s Laboratories Ltd, Cipla Limited, Lupin Limited, MundiPharma AG, Perrigo Company plc, Zydus Cadila
The prescription to over-the-counter (rx-to-otc) switches market report table of contents includes:
1. Executive Summary
2. Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Characteristics
3. Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Trends And Strategies
4. Prescription To Over-The-Counter (Rx-to-OTC) Switches Market – Macro Economic Scenario
5. Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Size and Growth
….
32. Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Competitive Benchmarking
33. Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Prescription To Over-The-Counter (Rx-to-OTC) Switches Market
35. Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Future Outlook and Potential Analysis
36. Appendix
List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
….
Table 74: Pfizer Inc. Financial Performance
Table 75: Johnson & Johnson Financial Performance
Table 76: Procter & Gamble Company Financial Performance
Table 77: Merck & Co. Inc Financial Performance
Table 78: AbbVie Inc. Financial Performance
Explore the trending research reports from TBRC:
https://goodprnews.com/biosensors-market-size/
https://goodprnews.com/clinical-nutrition-for-diabetes-care-market-share/
https://goodprnews.com/digital-twin-technology-market-segmentation/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The Dry Shampoo Market was valued at USD 6.37 billion in 2023 and is projected to reach…
Aircraft Engine Market Overview The global Aircraft Engine Market was valued at USD 90.11 billion in 2023 and is…
The vegan dog food global market report 2024 from The Business Research Company provides comprehensive…
Global 5G in Defense Market Overview: The 5G in Defense Market, valued at USD 690.06 million in…
Smart Railways Market: Transforming Global Transportation Smart Railways Market Overview The Smart Railways Market was valued at USD…
The palletizing robot global market report 2024 from The Business Research Company provides comprehensive market…